N
IMGN

Nuveen’s Immunogen Inc IMGN Stock Holding History

Nuveen’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,052,894
Closed -$60.9M – 3330
2023
Q4 		$60.9M Sell
2,052,894
-1,055,145
-34% -$21M 0.02% 539
2023
Q3 		$49.3M Buy
3,108,039
+465,505
+18% +$7.74M 0.02% 567
2023
Q2 		$49.9M Sell
2,642,534
-550,980
-17% -$6.51M 0.02% 576
2023
Q1 		$12.3M Buy
3,193,514
+1,905,334
+148% +$8.12M ﹤0.01% 1356
2022
Q4 		$6.39M Buy
1,288,180
+634,141
+97% +$3.44M ﹤0.01% 1775
2022
Q3 		$3.13M Sell
654,039
-304,512
-32% -$1.61M ﹤0.01% 2158
2022
Q2 		$4.31M Sell
958,551
-1,231,506
-56% -$5.35M ﹤0.01% 2044
2022
Q1 		$9.42M Buy
2,190,057
+1,415,091
+183% +$7.83M ﹤0.01% 1680
2021
Q4 		$4.75M Sell
774,966
-55,057
-7% -$342K ﹤0.01% 2158
2021
Q3 		$4.81M Sell
830,023
-64,892
-7% -$375K ﹤0.01% 2235
2021
Q2 		$5.9M Sell
894,915
-15,856
-2% -$111K ﹤0.01% 2165
2021
Q1 		$7.38M Buy
910,771
+49,859
+6% +$407K ﹤0.01% 1958
2020
Q4 		$5.55M Buy
860,912
+26,609
+3% +$155K ﹤0.01% 2019
2020
Q3 		$3M Sell
834,303
-135,220
-14% -$546K ﹤0.01% 2184
2020
Q2 		$4.46M Sell
969,523
-345,483
-26% -$1.47M ﹤0.01% 1962
2020
Q1 		$4.48M Buy
1,315,006
+661,249
+101% +$2.89M ﹤0.01% 1774
2019
Q4 		$3.34M Sell
653,757
-35,188
-5% -$119K ﹤0.01% 2198
2019
Q3 		$1.67M Sell
688,945
-16,606
-2% -$44.1K ﹤0.01% 2485
2019
Q2 		$1.53M Buy
705,551
+636,449
+921% +$1.51M ﹤0.01% 2560
2019
Q1 		$187K Hold
69,102
– – ﹤0.01% 1000
2018
Q4 		$332K Hold
69,102
– – ﹤0.01% 876
2018
Q3 		$654K Buy
69,102
+7,153
+12% +$68.8K ﹤0.01% 817
2018
Q2 		$603K Hold
61,949
– – ﹤0.01% 843
2018
Q1 		$652K Hold
61,949
– – ﹤0.01% 847
2017
Q4 		$397K Hold
61,949
– – ﹤0.01% 943
2017
Q3 		$474K Sell
61,949
-2,800
-4% -$18.6K ﹤0.01% 920
2017
Q2 		$460K Sell
64,749
-4,179
-6% -$19.1K ﹤0.01% 945
2017
Q1 		$267K Sell
68,928
-1,095
-2% -$3.2K ﹤0.01% 1281
2016
Q4 		$143K Sell
70,023
-300
-0.4% -$602 ﹤0.01% 1463
2016
Q3 		$188K Hold
70,323
– – ﹤0.01% 1344
2016
Q2 		$217K Sell
70,323
-265
-0.4% -$1.66K ﹤0.01% 1253
2016
Q1 		$601 Buy
70,588
+58,411
+480% +$494K ﹤0.01% 1182
2015
Q4 		$165 Sell
12,177
-247
-2% -$3.04K ﹤0.01% 1456
2015
Q3 		$119 Hold
12,424
– – ﹤0.01% 1499
2015
Q2 		$179 Sell
12,424
-281
-2% -$3.09K ﹤0.01% 1537
2015
Q1 		$114K Hold
12,705
– – ﹤0.01% 1539
2014
Q4 		$78K Sell
12,705
-389
-3% -$3.56K ﹤0.01% 1575
2014
Q3 		$139K Hold
13,094
– – ﹤0.01% 1523
2014
Q2 		$155K Hold
13,094
– – ﹤0.01% 1529
2014
Q1 		$195K Hold
13,094
– – ﹤0.01% 1509
2013
Q4 		$192K Buy
13,094
+510
+4% +$7.84K ﹤0.01% 1492
2013
Q3 		$214K Sell
12,584
-49,491
-80% -$870K ﹤0.01% 1402
2013
Q2 		$1.03M Buy
+62,075
New +$1.01M 0.01% 1018

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Nuveen's IMGN Position: Q1 2024 in Review

Nuveen sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 2,052,894 shares — an estimated $60.9M sold.

Nuveen first reported a position in IMGN in Q2 2013 and held it in 43 quarters. The position peaked at $60.9M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Nuveen reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Nuveen sold 2,052,894 Immunogen Inc shares in Q1 2024, an estimated $60.9M.
  • Nuveen first reported a position in Immunogen Inc in Q2 2013 and held it in 43 quarters.
  • Nuveen's Immunogen Inc position peaked at $60.9M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Nuveen's 13F filing for Q1 2024, filed 13 May 2024.